FebruaryAcquired the license for medical device manufacturing
Marchcompleted suscessfully “clinical trial study” for CardiaI priduct & service in circulatory
medicine, Seoul National Unviersity Hospital.
- electrocardiogram data analysis and reading of heart disease (arrhythmia) based on artificial intelligence algorithm
Aprilcontracted with international business partners including Africa (Kyena, tangania, Uganda etc.,), Indonesia etc.,
MayAcquired the Certificate of CE (MDD) for ambulatory ECG sysetm, EN ISO13485
Junemedifarmsoft was selected as a host institute for “a non-face-to-face startup nurturing project in“2021” by Korea Health Industry Development Institute“.
Junemedifarmsoft was selected as a Host Institute for Research & Development project by
The Ministry of SME & Startup, Republic of Korea :
- Analysis of multiple biomarkers for inspection of infectious disease for hospital medical staff and visitors, research and development of a kiosk system that detects anomalies based on artificial intelligence.
JulyCardiaI product acquired approval of manufacturing of Medical Device Item (MFDS : Ministry of Food & Drug Safety, Republic of Korea)
Julymedifarmsoft was selected as a particiapting institute for “Research & Development for
medical device” by All Ministry, Republic of Korea :
- Project : Research & Development of a platform for predicting the occurrence of atrial fibrillation through ECG reading by using 12 lead based on artificial intelligence
2020- Acquired GMP, the Certificate of Venture Company, Research & Development Institute
- Registered Patent : AI based reading system for ECG data
- Prototyping for Ambulatory ECG, CardiaI : Analysis of ECG data and reading algorithm software of arrhythmia based on Aritificial Intelligence
2019medifarmsoft was selected as a host institute for research & development project :“Deep- Learning based an early diagnosis and reading algorithm software” by NIPA (National IT Industry Promotion Agency)
2018.05The company, “medifarmsoft Co., Ltd.” is established.